Home > News > Archives > 2005 >

2005 News Misdosing common for powerful anti-clotting drugs Arthritis drug effective for depression in psoriasis sufferers Anti-heparin antibody predicts increased risk after heart surgery SYNERGY: Study compares use of anti-clotting drugs for heart patients U.S. heart patients receive more transfusions than international patients Wide racial disparities found in heart device implantation Physicians slower to incorporate newer heart drug treatments Drug not effective in preventing bypass vein clogging CRUSADE: Elderly patients with acute coronary syndrome less likely to get recommended care DCRI researchers help create first-ever Appropriateness Criteria for cardiovascular imaging Clinical outcomes in ENDEAVOR III stent study consistent with previous Endeavor trials More heart attack patients die in December New insights into cost-effectiveness of implanted heart device ESCAPE: Catheter procedure does not increase mortality in advanced heart failure patients ESCAPE: Pulmonary artery catheter use neutral for patient outcomes Discovery links blood cell defect to common lung disorder, leads to novel treatment Predicting infection risk for cardiac surgery patients Zoledronic acid faster, more effective treatment for Paget's Disease Nitroglycerin: not for everyone with chest pain? Quality of care for heart attack patients needs improvement Results of first multicenter trial of intercessory prayer, healing touch in heart patients CRUSADE: Increased risk of death with IV morphine use? Do we need more heart surgeons? One consequence of medical progress: the rise of health care-related infections Increased risk of sudden death within 30 days after a heart attack Dr. Eugene A. Stead, Jr. dies at 96 The impact of stress, mood, and loneliness on juvenile arthritis CAPTN: practical clinical trials in psychiatry The DCRI's Reed wins new investigator award Morphine for chest pain increases death risk Researchers analyze cost-effectiveness of ICDs in heart attack patients New study evaluates cost-effectiveness of defending against anthrax bioterrorism Bad outcomes related to, but not caused by, misdosing of clotbusters in heart attack patients CADILLAC: Body size may contribute to higher death rate for female heart attack patients PREVENT IV results announced CRUSADE: Treatment differences between white and black heart attack patients Dr. Califf summarizes coxibs issues at ACC EMERALD study: no benefit from protection device for heart attack patients Increase in WBCs linked to increased muscle damage and higher death rate Routine HIV screening should be expanded European Union Supports Trial Research for Children Secondhand smoke increases women’s risk of dying from heart disease DCRI joins Clinical Research Information Center Improving outcomes for heart attack patients DCRI's Hernandez wins Parmley Award

© 2003-2008 Duke Clinical Research Institute.